1. OFFICIAL - SENSITIVE COMMERCIAL
Immunoglobulin
Procurement Update
14th December 2018
Commercial Medicines Unit
OFFICIAL - SENSITIVE COMMERCIAL

2. OFFICIAL - SENSITIVE COMMERCIAL
Who Are We & What Do We Do?
CMU (Commercial Medicines Unit)
Specialised Commissioning
National & Regional Frameworks
NHS Secondary Care Medicines
Analysis
SRM
Commercial Medicines Unit
OFFICIAL - SENSITIVE COMMERCIAL

3. OFFICIAL - SENSITIVE COMMERCIAL
Why Do We Do What We Do?
CMU
Market Management
Innovation
Quality
Equality
Standardisation
Economies of Scale
Law
Commercial Medicines Unit
OFFICIAL - SENSITIVE COMMERCIAL

4. OFFICIAL - SENSITIVE COMMERCIAL
Framework – Then & Now
June 15 – May 16
5.40m Grams
June 16 – May 17
5.69m Grams (+5.4%)
July 17 – June 18
6.17m Grams (+8.4%)
July 18 – June 19
6.78m Grams (+9.9%)
Commercial Medicines Unit
OFFICIAL - SENSITIVE COMMERCIAL

5. OFFICIAL - SENSITIVE COMMERCIAL
Framework – The Future
Access to Stock
Price
Availability
Extension and Beyond
The B Word
Statutory Pricing Scheme
Medicines Optimisation
Commercial Medicines Unit
OFFICIAL - SENSITIVE COMMERCIAL

6. OFFICIAL - SENSITIVE COMMERCIAL
The Global Market
Demand
10 – 12% Growth
Pricing
IVIg – $55 per gram (£43 per gram)
SCIg – $63 per gram (£49 per gram)
Impact
Infrastructure
Plasma
Far East
Exchange Rates
Commercial Medicines Unit
OFFICIAL - SENSITIVE COMMERCIAL

7. OFFICIAL - SENSITIVE COMMERCIAL
What Are We Asking?
Database
5.49m Grams Recorded (Year 1)
6.17m Grams Sales Data (Year 1)
89% Complete Volumes
Forecasts
43% Year 1 Response Rate
90% Year 2 Allocation Response Rate
Trust Engagement
Commercial Medicines Unit
OFFICIAL - SENSITIVE COMMERCIAL

8. Questions? darryn.boardman@nhs.net 01138 070 456 07702 410 392
Commercial Medicines Unit
OFFICIAL - SENSITIVE COMMERCIAL